# A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes

> **NCT04569994** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 68 (actual)

## Conditions studied

- Healthy Volunteers
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** NNC0363-0845
- **DRUG:** Placebo (NNC0363-0845)
- **DRUG:** Insulin degludec

## Key facts

- **NCT ID:** NCT04569994
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2021-06-23
- **Final completion:** 2021-06-23
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569994, "A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04569994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*